Latest Stock Market News

S&P 500 earnings are expected to have climbed 6.1% for the second quarter from the year-ago period, according to IBES data from Refinitiv. Along with inflation and rising interest rates, investors have been concerned about the impact of currency headwinds and lingering supply chain issues for companies this earnings season.

The U.S. central bank is widely expected to raise interest rates by 75 basis points at the conclusion of its policy meeting on Wednesday. A hike of that magnitude would effectively close out pandemic-era support for the economy.

Asian Paints, L&T, Bajaj Auto, Tata Power, United Spirits, Union Bank of India, Relaxo Footwears, Sanofi, Aditya Birla SL AMC, KEI Industries, and UTI AMC are among the companies that will announce their earnings for the quarter ended June 2022.

Prabhakar said the bank has increased its provision coverage ratio (PCR) to 84% this year from 70% in March 2020 as a prudent measure and expects to keep PCR at 85% at the end of the fiscal.

Tata Steel had earlier said its board would consider a proposal for sub-division of the equity shares of the company having a face value of Rs 10 each.

This is a welcome added boon for Americans travelling to one of the 19 countries that use the euro and a small consolation for European tourists in the United States. No more mental arithmetic is required to convert between dollars and euros - you can call it pretty much one for one now

Oil futures have been volatile in recent weeks as traders have tried to reconcile the possibilities of further interest rate hikes, which could limit economic activity and thus cut fuel demand growth, against tight supply from disruptions in trading of Russian crude because of Western sanctions amid the Ukraine conflict.

The company had a net profit of Rs 305.84 crore in the same period of 2021-22, JSL said in regulatory filing.Its total income rose to Rs 5,490.91 crore, about 36 per cent up compared to Rs 4,042.32 crore in the year-ago period.Expenses increased to Rs 5,089.45 crore in the quarter from Rs 3,610.89 crore in the April-June quarter of the

"Our results reflect good momentum across general medicines and vaccines during the quarter. We have delivered strong underlying growth with market share gains across focus brands," GlaxoSmithKline Pharmaceuticals MD Sridhar Venkatesh noted.

Net interest margin of the bank rose to 3.82 per cent in the latest quarter under review from 3.55 per cent in the same period a year ago.Total income rose to Rs 1,672.60 crore in Q1FY23 as against Rs 1,579.26 crore in Q1FY22.At the end of June, Gross Non Performing Assets (NPAs) fell to 5.21 per cent of the gross advances from 7.97 per cent at the end of June 2021.